Background: No clear clinical guidelines exist on anticoagulant use for chronic kidney
disease (CKD) patients. We compared the efficacy and safety of direct-acting oral …

Gastrointestinal bleeding (GIB) is the most common type of bleeding occurring in patients on
oral anticoagulation. A meta-analysis of the landmark randomized controlled trials (RCTs) …

Results: A total of 46 studies were included. Apixaban was associated with a reduced risk of
GIH compared with Dabigatran (HR: 0.67, 95% CI, 0.56 to 0.81, I 2: 53.28%), Rivaroxaban …

Introduction For a long time, vitamin K antagonists (VKA) were the only oral anticoagulation
therapy available to reduce adverse events in atrial fibrillation (AF) patients. Direct-acting …

Objetivos El objetivo consistía en evaluar un programa de gestión de anticoagulantes orales
directos (ACOD) en pacientes con fibrilación auricular no valvular (FANV) según sus …

Antithrombotic agents are widely used on the globe for prevention of thrombotic events such
as atherothrombotic events and thromboembolic stroke in atrial fibrillation or for prevention …

Introduction Atrial fibrillation (AF) is one of the leading causes of cerebrovascular mortality
and morbidity. Oral anticoagulants (OACs) have been shown to reduce the incidence of …

Approval of direct‐acting oral anticoagulants (DOACs) for stroke prevention in atrial
fibrillation (AF) was an important milestone, providing a wider range of treatment options and …

Abstract Introduction Direct oral anticoagulants (DOACs) changed the landscape of atrial
fibrillation (AF) treatment, but also brought with them new challenges in terms of accessibility …

The use of anticoagulants has become more frequent due to the progressive aging
population and increased thromboembolic events. Consequently, the proportion of …